As of 2024-12-14, the Intrinsic Value of Outlook Therapeutics Inc (OTLK) is
-19.88 USD. This OTLK valuation is based on the model Peter Lynch Fair Value.
With the current market price of 1.48 USD, the upside of Outlook Therapeutics Inc is
-1,442.91%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-19.88 USD
Intrinsic Value
OTLK Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-19.88 - -19.88 |
-19.88 |
-1,442.91% |
| P/E |
(82.36) - (76.40) |
(89.04) |
-6116.2% |
| DDM - Stable |
(20.91) - (153.08) |
(87.00) |
-5978.2% |
| DDM - Multi |
(0.46) - (2.64) |
(0.78) |
-152.5% |
OTLK Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
35.02 |
| Beta |
0.15 |
| Outstanding shares (mil) |
23.66 |
| Enterprise Value (mil) |
35.42 |
| Market risk premium |
4.60% |
| Cost of Equity |
11.82% |
| Cost of Debt |
5.00% |
| WACC |
8.39% |